Subtitle

Healthcare

Other SubTitle

Our research field

Keratia is actively developing algorithm in the field of healthcare AI and biotechnology, specializing in o proprietary machine learning algorithms designed to predict disease progression, assess risk, and optimize treatment strategies. Our innovative solutions leverage advanced data analytics, deep learning, and biomedical research to address some of the most pressing challenges in modern medicine.

Our technology

Our proprietary machine learning algorithms are designed to analyze complex medical data, uncover hidden patterns, and provide actionable insights. Our technology focuses on:

Predicting Disease Progression: Using advanced AI models to forecast how diseases will evolve over time, enabling proactive interventions.
Risk Assessment: Estimating the likelihood of developing conditions such as diabetes and Alzheimer’s disease, allowing for early detection and prevention.
Cancer Progression Studies: Analyzing tumor growth, treatment responses, and patient outcomes to optimize cancer care.

Our algorithms are trained on large-scale, diverse predictors and are continuously refined to ensure accuracy, reliability, and clinical relevance

Redefining Intelligence. Delivering Precision.

Our Solutions

We’ve developed a suite of AI-powered solutions to address key challenges in modern agriculture

01

Predictive Disease Progression Models

Our AI-driven models predict how diseases will progress in individual patients, helping clinicians to tailor treatment plans and interventions. By analyzing patient-specific data, our algorithms provide personalized forecasts that improve patient outcomes and reduce healthcare costs.

02

Diabetes and Alzheimer’s Risk Assessment

Using machine learning and predictive analytics, we assess an individual’s likelihood of developing diabetes or Alzheimer’s disease. Our models integrate genetic, lifestyle, and clinical data to provide early warnings and enable preventive measures.

03

Cancer Progression Analysis

Our algorithms study cancer progression, treatment efficacy, and patient responses to therapies. By identifying key biomarkers and patterns, we help oncologists to design personalized treatment plans and improve survival rates.